Statins and Cognition in Parkinson’s Disease

Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database

(2017) Guodong Liu et al.   MOVEMENT DISORDERS

Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease

(2016) Naveed Malek et al.   MOVEMENT DISORDERS

Confounding of the association between statins and Parkinson disease: systematic review and meta-analysis

(2016) Katsiaryna Bykov et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire

(2015) Laura Brennan et al.   MOVEMENT DISORDERS

Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients

(2015) Christine R. Swanson et al.   MOVEMENT DISORDERS

Longitudinal study of normal cognition in Parkinson disease

(2015) Kara Pigott et al.   NEUROLOGY

Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype

(2014) Christine R. Swanson et al.   MOVEMENT DISORDERS

Plasma apolipoprotein A1 as a biomarker for Parkinson disease

(2013) Judy K. Qiang et al.   ANNALS OF NEUROLOGY

Statins Exert the Pleiotropic Effects Through Small GTP-Binding Protein Dissociation Stimulator Upregulation With a Resultant Rac1 Degradation

(2013) Shin-ichi Tanaka et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Discontinuation of statin therapy associates with Parkinson disease: A population-based study

(2013) Y.-C. Lee et al.   NEUROLOGY

Prospective Study of Statin Use and Risk of Parkinson Disease

(2012) Xiang Gao   ARCHIVES OF NEUROLOGY

Vascular Degeneration in Parkinson's Disease

(2012) Jian Guan et al.   BRAIN PATHOLOGY

Statin use and risk of Parkinson’s disease: a meta-analysis of observational studies

(2012) Krishna Undela et al.   JOURNAL OF NEUROLOGY

Statins in the prevention of dementia and Alzheimer's disease: A meta-analysis of observational studies and an assessment of confounding

(2012) William B. Wong et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Pravastatin and cognitive function in the elderly. Results of the PROSPER study

(2009) Stella Trompet et al.   JOURNAL OF NEUROLOGY

Statin-Associated Adverse Cognitive Effects: Survey Results from 171 Patients

(2009) Marcella A Evans et al.   PHARMACOTHERAPY

Effect of Dobutamine and Hyperoxia on Free Radicals Production in Relation to the Ultrastructural Alterations in the Endothelial of Myocardial Capillary in Rats,Rattus norvigicus

(2009) Essam H. Mattar et al.   ULTRASTRUCTURAL PATHOLOGY

Clock drawing performance in cognitively normal elderly

(2008) E HUBBARD et al.   ARCHIVES OF CLINICAL NEUROPSYCHOLOGY

General Cardiovascular Risk Profile for Use in Primary Care

(2008) Ralph B. D’Agostino et al.   CIRCULATION

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

(2008) Mariese A. Hely et al.   MOVEMENT DISORDERS